Scott Hutton - 12 Aug 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Reporting relationship: President & CEO, Director
Issuer ticker: BDSX
Reported as of: 12 Aug 2025
Net transaction value: -$1,570
SEC form: 4
Accepted by SEC: 14 Aug 2025, 17:25:03 UTC
Prior SEC filing: 13 May 2025
Next SEC filing: 13 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton

Key filing fact

Scott Hutton filed Form 4 for BIODESIX INC (BDSX) on 14 Aug 2025.

Key facts

This page summarizes Scott Hutton's Form 4 filing for BIODESIX INC (BDSX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 Aug 2025, 17:25.

Change

Previous filing in this sequence was filed on 13 May 2025.
Current net transaction value: -$1,570.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001697361 Primary reporting owner

Hutton Scott

Relationship: President & CEO, Director
Address: 919 WEST DILLON RD, LOUISVILLE
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton
Signature date: 14 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDSX transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,212
Change %: +1.7%
Price
Shares after: 732,596
Date: 12 Aug 2025
Ownership: Direct
Footnotes: F1

BDSX transaction

Common Stock

Sale

Transaction value: $1,570
Shares: -3,772
Change %: -0.51%
Price: $0.4163
Shares after: 728,824
Date: 13 Aug 2025
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -12,212
Change %: -33%
Price: $0.000000
Shares after: 24,424
Date: 12 Aug 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,212
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.

Footnote F3

The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.4076 to $0.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.